SABSW
NASDAQ
SAB Biotherapeutics, Inc. - Warrant
$0.04
▲ +$0.00
(+0.00%)
Price Chart
Quarterly Revenue & Earnings
| Quarter | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Net Income | -$11.4M | -$5.2M | -$10.1M | $45.4M | -$16.9M |
Financial Health
Free Cash Flow
-$17.7M
Net Debt
-$4.6M
Cash
$10.5M
Total Debt
$6.0M
As of Dec 31, 2025
Top Holders
Top 5: 4.77%Morgan Stanley
2.55%
$4K
Clear Street Group Inc.
1.37%
$2K
Gts Securities LLC …
0.71%
$1K
UBS Group AG
0.11%
$169
Wolverine Asset Management,…
0.03%
$49
As of Dec 31, 2025
Latest News
No related news yet